Home
Clinical Resources Search
PQI: Imetelstat (RYTELO®) in the treatment of low-to-intermediate-1-risk myelodysplastic syndromes (MDS)

Imetelstat (RYTELO®) in the treatment of low-to-intermediate-1-risk myelodysplastic syndromes (MDS)

Download PQI pdf 0.24MB

Last Updated: February 20, 2025

By: Caroline Jones, PharmD

About this PQI

The purpose of this PQI is to discuss clinical considerations around the use of imetelstat (RYTELO®) to optimize outcomes for patients with low-to-intermediate-1-risk myelodysplastic syndromes (MDS).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Myelodysplastic Syndrome (MDS)

PQI

Frequently Searched

Supported by

Imetelstat (RYTELO®) in the treatment of low-to-intermediate-1-risk myelodysplastic syndromes (MDS)

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

PQI in Action: Proactive Symptom Management in Myelofibrosis

PQI in Action: Sonidegib (Odomzo®) Patient Management

S9 E2: Love Languages in Cancer Care

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

S8 Bonus Eps 2: Inside ASCO 2025

S8 E15: Supporting Survivors at Work

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies

PQI: Erythropoietin Stimulating Agent Ineligibility in Myelodysplastic Syndromes

PQI in Action: Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies

PQI in Action: Erythropoietin Stimulating Agent Ineligibility in Myelodysplastic Syndromes

S9 E2: Love Languages in Cancer Care

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice